Faculty Information - Shunichi Fujita

（Last updated : 2025-03-18 09:43:01）

Shunichi Fujita
Department Kawasaki Medical School Kawasaki Medical School, Department of Rheumatology,

Position Assistant Professor

■ Journal

1.	2025/02/26	Clinical Significance of Antinuclear Antibodies in Patients with　Rheumatoid Arthritis: From SETOUCHI-RA Registry
2.	2024/03/21	Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis
3.	2022/11/15	Acromegaly: A Rare Cause of Knee Pain
4.	2022/08	Iliopectineal bursitis
5.	2022/05/14	IL-17A promotes vascular calcification in an ex vivo murine aorta culture
6.	2022/03/10	IL-17A promotes vascular calcification in an ex vivo murine aorta culture
7.	2021/09	Barium‐induced pneumatosis intestinalis in a patient with anti‐synthetase syndrome
8.	2021/08/31	The "Ant-farm"-like Appearance of Restricted Lower Limb Vasculitis on Fluorodeoxyglucose-positron Emission Tomography: A Case Series
9.	2021/06/18	A tiger man: a case of muscular sarcoidosis
10.	2021/03	Severe oral stomatitis due to reactivation of herpes simplex virus type 1 in a methotrexate-treated patient with dermatomyositis.
11.	2021/01	Certolizumab pegol-induced immunoglobulin A vasculitis in a patient with rheumatoid arthritis
12.	2021/01	Tattoo skin reaction as a skin manifestation of systemic sarcoidosis
13.	2020/06/10	Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis
14.	2020/02	Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should be Treated with Low-dose Prednisolone During Pembrolizumab Therapy
15.	2019/07/15	Japanese Spotted Fever: A Rare Cause of Arthritis
16.	2019/07	Tuberculous fasciitis in a patient with systemic lupus erythematosus.
17.	2019/05	Infection of Helicobacter cinaedi Should be Treated for an Adequate Duration with Combined Antibiotic Therapy: Author's Reply.
18.	2019/02/22	Tankyrase (PARP5) Inhibition Induces Bone Loss through Accumulation of Its Substrate SH3BP2.
19.	2019/01	Complete resolution of giant cell arteritis after tocilizumab monotherapy determined by positron emission tomography-CT
20.	2018/12	Bacteremia possibly caused by Helicobacter cinaedi and associated with painful erythema in rheumatoid arthritis with malignant lymphoma
21.	2018/10	Bladder carcinoma in situ in a patient with lupus cystitis
22.	2018/03	IgG4-related autoimmune pancreatitis complicated by splenic artery pseudoaneurysm.
23.	2018/03	Treatment of refractory rheumatoid pleural effusion with abatacept.
24.	2018/01	Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
25.	2015/04	Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis
26.	2014/07	ACT-Ray study
Display 5 items
Display all(26)

■ Presentation

1.	2022/09/07	“Ant-farm”-like Appearance; Characteristic F-18 Fluorodeoxyglucose Positron-Emission Tomographic Findings of Restricted （Poster notice，Keynote）
2.	2021/04/26	Excessive Angiotensin II exacerbates bone erosion in a murine tumor necrosis factor-mediated arthritis model （Speech）
3.	2020/10/24	Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis （Poster notice，General）
4.	2019/04/17	SH3BP2 gain-of-function mutation ameliorates lupus in B6.MRL-Faslpr mice （Speech，General）
5.	2018/04/27	Bone systemic administration of angiotensin II and its type 1 receptor gene deletion exacerbates erosive bone destruction in hTNF-transgenic arthritis mice （Speech，General）
6.	2018/04/27	Myostatin inhibition reduces bone loss in an unloading osteoporosis model （Speech，General）
7.	2018/04/27	Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastgenesis （Speech，General）
8.	2018/04/27	SH3BP2 gain-of-function mutation alleviates lupus phenotypes in B6.MRL-Faslpr mice （Speech，General）
9.	2018/04/26	Functional analysis of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF receptor-associated periodic syndrome(TRAPS) （Speech，General）
10.	2017/11/07	SH3BP2 Gain-of-Function Mutation Ameliorates Lupus in B6.MRL-Faslpr Mice （Poster notice，General）
11.	2017/11/06	Angiotensin II Type I Receptor Deficiency Exacerbates Erosive Bone Destruction ofhTNF-Transgenic Arthritis Mice （Poster notice，General）
12.	2017/11/05	Functional Analysis of the Novel G58V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS) （Poster notice，General）
13.	2017/11/05	Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2 （Poster notice，General）
14.	2017/11/05	The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models （Poster notice，General）
15.	2017/09/18	Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via SH3BP2 （Poster notice，General）
16.	2017/04/21	Tankyrase regulates bone mass and osteoclastogenesis （Speech，General）
17.	2017/04/20	Angiotensin II exacerbates bone destruction in human TNF-transgenic arthritis mice （Speech，General）
18.	2017/04/20	The effect of myostatin inhibition on bone loss in murine osteoporosis models （Poster notice，General）
19.	2016/11/14	Tankyrase Regulates Osteoclastogenesis Via SH3BP2 （Poster notice，General）
20.	2016/11/13	Angiotensin II Exacerbates Bone Destruction in TNF-Transgenic Arthritis Mice （Poster notice，General）
21.	2016/04/23	Tankyrase Inhibitor Promotes Osteoclastogenesis by Enhancing SH3BP2 expression （Speech，General）
22.	2015/11/16	Tankyrase regulates osteoclastogenesis via SH3BP2 expression （Poster notice，General）
23.	2012/05/09	Biological agents for rheumatoid arthritis (RA) after the short term remission of methotrexate-associated lymphoproliferative disorders (MTX-LPD) （Speech，General）
Display 5 items
Display all(23)